CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 97 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $234,934 | -99.2% | 10,762 | -98.8% | 0.00% | -98.6% |
| Q2 2023 | $28,953,124 | +54.5% | 910,762 | +18.5% | 0.15% | +19.7% |
| Q1 2023 | $18,738,252 | +26.1% | 768,276 | +63.0% | 0.12% | +3.4% |
| Q4 2022 | $14,865,275 | +1.5% | 471,315 | -9.1% | 0.12% | +26.9% |
| Q3 2022 | $14,646,000 | +10.8% | 518,276 | +3.7% | 0.09% | +19.2% |
| Q2 2022 | $13,220,000 | -49.7% | 500,000 | -33.3% | 0.08% | -33.9% |
| Q1 2022 | $26,258,000 | +8.0% | 750,000 | 0.0% | 0.12% | +29.7% |
| Q4 2021 | $24,315,000 | +9.9% | 750,000 | 0.0% | 0.09% | +1.1% |
| Q3 2021 | $22,125,000 | +1627.2% | 750,000 | +1400.0% | 0.09% | +1400.0% |
| Q2 2021 | $1,281,000 | – | 50,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,713,470,000 | 41.39% |
| Perceptive Advisors | 6,511,727 | $184,021,000 | 5.34% |
| Finepoint Capital LP | 536,901 | $15,173,000 | 4.99% |
| Artal Group S.A. | 2,000,000 | $56,520,000 | 2.41% |
| Rock Springs Capital Management LP | 2,499,148 | $70,626,000 | 1.82% |
| Ikarian Capital, LLC | 178,100 | $5,033,000 | 1.00% |
| Hood River Capital Management LLC | 896,572 | $25,337,000 | 0.97% |
| Frazier Life Sciences Management, L.P. | 393,000 | $11,106,000 | 0.86% |
| HighVista Strategies LLC | 23,611 | $667,000 | 0.38% |
| FEDERATED HERMES, INC. | 3,313,333 | $93,635,000 | 0.27% |